Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Confirmed Asymptomatic and mildly symptomatic cases of COVID-19 infection by laboratory tests Age limit 18 to 60 years both Male and Female Uncomplicated cases of COVID - 19 patients on Allopathic medication Patients in whom ventilator support is not required Patients with no associated co morbidities Patients willing to give informed consent to participate in the clinical trial
Exclusion criteria
Exclusion criteria: COVID-19 positive patients above 60 years of age & below 18 years with Symptoms. Patients with associated comorbidities like hypertension, type 2 or type 1 diabetes mellitus, chronic or acute renal failure Patients on Immuno-suppression therapy Pregnant Women or lactating mothers Patients in advanced stage of disease requiring emergency medical intervention like pneumonia, bronchial asthma, organ failure
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Early recovery in the signs and symptoms of cases of Asymptomatic and mild symptomatic COVID-19 patients by adding Ayurvedic medicines which are effective in enhancing immunity of body and reducing the symptoms such as Fever and respiratory distressTimepoint: Day 1 and Day 30 | — |
Secondary
| Measure | Time frame |
|---|---|
| a. TNF-α b. IL-6 c. IFN- β d. IFN-λTimepoint: Day 1 and Day 30 | — |
Countries
India
Contacts
Bangalore Medical College research Institute